Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm-associated antigen 1 (SPAG1) is a cytoskeletal-associated GTPase protein encoded by the SPAG1 gene located on chromosome 8q22.2. It was originally identified as a component of the sperm tail and is involved in the structural integrity and motility of spermatozoa[2][3]. SPAG1 binds GTP and possesses GTPase activity, playing a key role in the regulation of GTP-mediated signal transduction pathways important for spermatogenesis and fertilization[3][4]. It is also implicated in the cytoplasmic assembly of ciliary dynein arms and is necessary for meiotic progression in germ cells[3]. SPAG1 has clinical significance outside reproduction, with high expression levels observed in several cancers, including breast cancer, where it promotes tumor cell proliferation and is associated with worse prognosis[1]. Mutations in SPAG1 are linked to primary ciliary dyskinesia (a ciliopathy, CILD28) and certain forms of epilepsy[3]. SPAG1 is being studied both as a potential biomarker for infertility and cancer prognosis and as an immunogen in autoimmunity or contraception research[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm-associated antigen 1 (SPAG1).